Adaptive Biotechnologies and Microsoft team up to track coronavirus-fighting cells

GeekWire

Seattle-based Adaptive Biotechnologies and Microsoft have launched an open-access database called ImmuneCODE to catalog the many ways in which our immune systems fight off a coronavirus infection. Check out this GeekWire Health Tech Podcast for more about Adaptive Biotechnologies’ collaboration with Microsoft on COVID-19 studies. Health/Life Sciences Science Adaptive Biotechnologies coronavirus immune system immune therapy ImmuneCODE Microsoft Microsoft Health

Adaptive Biotechnologies will sell 8M shares to accelerate drug development

GeekWire

Adaptive Biotechnologies announced Tuesday that it will sell 8 million shares of its common stock — 6 million of its own, and 2 million from an investor — to help accelerate the company’s work. Health/Life Sciences Adaptive BiotechnologiesThe money will go toward investments in its TCR-Antigen Map activities, marketing activities associated with immunoSEQ Dx clinical products and services, and continued R&D for drug discovery initiatives.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Machine learning and microbes: How big data is redefining biotechnology

Tech Republic Big Data

As interesting as big data can be in Silicon Valley, its most fascinating applications often happen elsewhere

This 35-year-old female CEO is about to crack the glass ceiling, shattering a dismal IPO track record

GeekWire

The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the first woman to guide a company to an initial public offering in Washington state in more than two decades. ” Startups Athira Pharma Biotechnology IPOs leen kawas

Merck’s multi-billion dollar bet on Seattle Genetics sparks hope for breast cancer treatments

GeekWire

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. Health/Life Sciences Biotechnology Seattle Genetics

Adaptive Biotech pushes ahead with new Seattle HQ, showing strength of life sciences industry

GeekWire

Chad Robins, CEO of Adaptive Biotechnologies, speaks at the site of the company’s future corporate headquarters in Seattle, standing in front of the final piece of structural steel before it’s put into place. Stephen Brashear/AP Images for Adaptive Biotechnologies). But the recent event held by Adaptive Biotechnologies carried extra symbolic significance, due to the events swirling around it. The future home of Adaptive Biotechnologies at 1165 Eastlake Avenue E.

Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19

GeekWire

OncoSenX is the spinoff of a third company, Seattle-based Oisin Biotechnologies. Tech Biotech Biotechnology COVID-19 COVID-19 vaccine oncosenxJohn Lewis, co-founder and chief scientific officer at Seattle’s OncoSenX, and co-founder and CEO of Entos Pharmaceuticals in Edmonton, Alberta. LinkedIn Photo). A researcher with ties to Seattle-based biotech company OncoSenX has received a $4.2

Inside the quest for a new COVID-19 test: Microsoft, Adaptive Biotech and the hidden power of immunity

GeekWire

Two companies in the Seattle region, Microsoft and Adaptive Biotechnologies, are on a quest to create a better diagnostic test. Health Tech Podcast Adaptive Biotechnologies chad robins COVID-19 Microsoft Peter LeeAdaptive Biotech CEO Chad Robins (left) and Peter Lee, Microsoft corporate vice president of AI and Research, on a video call this week for GeekWire’s Health Tech Podcast.

Study 67

GeekWire Podcast: What pandemic? Tech funding stays strong; Accolade’s IPO; Future of sports

GeekWire

Health/Life Sciences Podcasts Startups Accolade Funding GeekWire Events IPO Sana BiotechnologyHere’s what we’re talking about on the GeekWire Podcast this week. Despite the pandemic, funding for Pacific Northwest tech startups remains robust in the first half of 2020.

Adaptive Biotech revenue rises 65% to $21M, loss widens amid big COVID-19 immune partnerships

GeekWire

Adaptive Biotechnologies CEO Chad Robins. Adaptive Biotechnologies, which is working with Microsoft and Amgen to fight COVID-19 using its technology for sequencing the human immune system, reported a 65% increase in first quarter revenue , to nearly $21 million. Health/Life Sciences Adaptive Biotechnologies Amgen chad robinsGeekWire File Photo).

Secretive Seattle biotech company raises more than $700M to develop new ways to modify genes

GeekWire

Sana Biotechnology today formally announced that it has raised more than $700 million in venture funding — one of the largest venture financing deals in the life sciences industry and one of the biggest rounds on record in Seattle. Health/Life Sciences Biotechnology Funding fundings sana Venture capitalSteve Harr (Sana Photo).

Harry Potter's invisibility cloak is almost a reality, but only for likely military use

Mashable VR

Canadian camouflage company Hyperstealth Biotechnology is working on a 'cloak' that can render some objects nearly invisible from certain angles. The cloak uses a technology called Quantum Stealth to bend light around people or objects.

Seattle biotech Athira Pharma sets terms for IPO, aims to raise up to $170M

GeekWire

Formerly known as M3 Biotechnology, the company is led by Leen Kawas, a 35-year-old CEO who would be the first woman to guide a company to an initial public offering in Washington state in more than two decades.

Seattle biotech startup led by Fred Hutch, Adaptive vets raises $16M for rapid drug development tech

GeekWire

Lumen is led by Finrow, a former senior vice president at Adaptive Biotechnologies, and Chief Science Officer Jim Roberts , the former head of basic sciences at the Fred Hutchinson Cancer Research Institute. Lumen Chief Science Officer Jim Roberts (left) and CEO Brian Finrow. Lumen Photo).

Athira Pharma prices IPO at $17/share, will raise $204M in third Washington state IPO of 2020

GeekWire

Formerly known as M3 Biotechnology, the company is led by Dr. Leen Kawas , a 35-year-old CEO who will be the first woman to guide a company to an initial public offering in Washington state in more than two decades. The Athira team. Athira Photo).

Seattle biotech startup OncoSenX raising more cash for cancer-fighting therapies

GeekWire

OncoSenX is a spinout out of Oisin Biotechnologies, a 5-year-old Seattle company also led by Scholz, a veteran biotech entrepreneur. Biotech startup OncoSenX is raising more cash to help support its pipeline of therapeutics that aim to kill cancer cells based on their genetics. Its technology targets solid tumors based on a patented lipid nanoparticle gene delivery system and a highly targeted DNA payload.

Microsoft releases preview of Text Analytics for health, battle-tested in COVID-19 partnership

GeekWire

” It’s the latest in a series of initiatives from Microsoft that apply artificial intelligence to health, life sciences and biotechnology. Bigstock Photo.

Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs

GeekWire

The company, previously known as M3 Biotechnology, is led by Dr. Leen Kawas , a 35-year-old entrepreneur originally from Jordan. It would be the first Seattle biotech to go public since Adaptive Biotechnologies IPO’d last year. The Athira team. Athira Photo).

Seattle biotech startup Athira raises $85M to develop therapies for Alzheimer’s and Parkinson’s

GeekWire

The company, previously known as M3 Biotechnology, is committed to growing in Seattle as part of the local biotech and life sciences ecosystem , Kawas said. Other fast-growing Seattle-area biotech startups include Nautilus Biotechnology, which just raised a $76 million Series B round to study the human proteome, Silverback Therapeutics, Phase Genomics, Good Therapeutics, Blaze Bioscience, and more. The Athira team. Athira Photo).

Bill Gates and Jeff Bezos-backed cancer detection company Grail, led by ex-Juno CEO, files for IPO

GeekWire

Bezos and Vulcan Capital, the firm founded by the late Microsoft co-founder Paul Allen, are backers of a similar Seattle startup called Nautilus Biotechnology that raised $76 million in May. Grail CEO Hans Bishop at the 2016 GeekWire Summit. GeekWire Photo / Dan DeLong).

Arizona State University Adopts Hortonworks Data Platform to Shed Light on the Genetic Links to Cancer

CTOvision

ASU researcher improves crop performance with new biotechnology (eurekalert.org). Katie Kennedy. Recently announced, Arizona State University (ASU) is using Hortonworks Data Platform (HDP™) to further cancer research. With HDP, ASU researchers have the tools they need to store, process, and query more data at a faster pace, allowing researchers to ask better questions and uncover new links between genetics and cancer.

Scientists say 17-year-old blood sample yields promising antibodies for COVID-19

GeekWire

Medications that make use of the antibodies are now on a fast-track development and testing path at California-based Vir Biotechnology in collaboration with GlaxoSmithKline , in preparation for clinical trials. The search for COVID-19 therapies has turned to an antibody that was first identified back in 2003, in a blood sample from a patient who recovered from a similar coronavirus-based disease.

Pacific NW startup funding totals for first half of 2020 may surprise you — in fact, they shocked us

GeekWire

As the chart at top shows, there was one whopper financing in June: Seattle-based Sana Biotechnology raised more than $700 million in one of the largest biotechnology funding deals ever. Recession? What recession?

Thanks Darpa: Minimally Invasive “Stentrode” Shows Potential as Neural Interface for Brain

CTOvision

In an article published in Nature Biotechnology , researchers in the Vascular Bionics Laboratory at the University of Melbourne led by neurologist Thomas Oxley, M.D., Bob Gourley. DARPA funded research has produced a device, called the "stentrode," capable of direct recording of brain activity, right from neurons. This amazing technology repurposes stent devices to enable this breakthrough. .

Next-gen vaccine from UW researchers shows promise in fighting COVID-19

GeekWire

LION was developed by the Seattle biotechnology company HDT Bio; Amit P. Deborah Fuller, left, and Jesse Erasmus are pursuing next-generation vaccines at the University of Washington. GeekWire Photo / Todd Bishop). University of Washington School of Medicine researchers using a cutting-edge approach to vaccinations report that their COVID-19 vaccine is performing well in mouse and non-human primate studies.

Good Therapeutics raises $11M to develop ‘context dependent’ protein drugs

GeekWire

Another Seattle biotech company, Nautilus Biotechnology, announced a $76 million funding round Thursday. Good Therapeutics CEO John Mulligan. Good Therapeutics Photo). Seattle biotech startup Good Therapeutics raised another $11 million to create “context dependent” protein drugs that act only when needed. The 4-year-old company is developing cytokines that regulate their own activity in response to biomarkers and metabolic signals, said CEO John Mulligan.

Fred Hutch and Allen Institute launch study of milder COVID-19 cases, aiming for unique insights

GeekWire

Adaptive Biotechnologies, for example, is using its immune sequencing platform in partnerships with Microsoft and Amgen in search of better COVID-19 tests and therapies. Researchers at the Allen Institute for Immunology processing COVID blood samples as part of a study announced today with the Fred Hutchinson Cancer Research Center. Allen Institute Photo).

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

GeekWire

He was COO at Seattle Genetics for 15 years and currently is a board member at Adaptive Biotechnologies and Atara Biotherapeutics. Chinook Therapeutics , a biotech company creating targeted therapies for kidney diseases, has agreed to merge with Berkeley, Calif.-based based Aduro Biotech. The proposed all-stock deal “is a unique opportunity for Chinook to build a leading company in the kidney disease space,” Chinook CEO Eric Dobmeier said in a statement.

Stock market rally: Amazon, Microsoft, other Seattle companies bounce back from March lows

GeekWire

Other Seattle-area companies seeing shares increase include Adaptive Biotechnologies (130%); Impinj (123%); Avalara (70%); Smartsheet (40%); and T-Mobile (40%). (Google Chart). stocks have come roaring back despite millions of people still unemployed due to pandemic-related layoffs and the threat of COVID-19 lurking. The S&P 500 was up more than 1% Monday as it returns to pre-COVID-19 levels following a massive drop in March due to the global pandemic.

Presenting the 2020 GeekWire Awards finalists: Who will be named the best in Pacific NW tech?

GeekWire

The finalists are: Adaptive Biotechnologies prices IPO at $20 per share. This pioneering health, life science, biotechnology or medical breakthrough holds great promise for making the lives of people better or improving the health care system. Sana Biotechnology. Voting is closed and the ballots are tallied. Now, the show must go on. The 2020 GeekWire Awards will take place at 4 p.m.

Fred Hutchinson Cancer Research Center cutting 76 jobs, citing impact of economic downturn

GeekWire

The institution is a life sciences and biotech powerhouse in the Seattle region, spinning off numerous startups and providing the scientific underpinnings for major companies including Adaptive Biotechnologies and Juno Therapeutics. The Fred Hutchinson Cancer Research Center’s headquarters in Seattle’s South Lake Union neighborhood. Fred Hutch Photo).

Benaroya Research Institute awarded $5.8M from NIH for immunology-related COVID research

GeekWire

They include a partnership between Adaptive Biotechnologies and Microsoft to map immune response to coronavirus, A-Alpha Bio’s research to identify antibodies that bind the virus, and the Infectious Disease Research Institute’s clinical trials using immunotherapy treatments.

GeekWire 200 update: Health tech and B2C startups rise up rankings of top PNW companies

GeekWire

Last year, there were only two IPOs among GeekWire 200 companies: Adaptive Biotechnologies and Limeade. The ongoing global pandemic is rewriting the startup playbook. Some companies have accelerated growth plans, many pivoted or reduced staff, and others are cautiously charging ahead.

B2C 85

Accolade sets terms for IPO, aims to raise up to $211M in Seattle’s first public offering this year

GeekWire

Accolade would be the first Seattle-area company to go public since Adaptive Biotechnologies last year. Accolade CEO Raj Singh speaking at the 2018 GeekWire Summit. GeekWire Photo / Dan DeLong). Accolade set the terms for its IPO on Wednesday as the health benefits platform aims to become the first Seattle-area company to go public in 2020. The startup will price 8.75 million shares at between $19 and $21, raising as much as $211 million and valuing the company at around $1 billion.

Athira Pharma raises $204M in IPO, reaching ‘big milestone’ in fight against Alzheimer’s and other diseases

GeekWire

” Athira, previously known as M3 Biotechnology, plans to double the size of its 20-person team as it relocates into a larger facility in Bothell, Wash. Athira Pharma CEO Leen Kawas accepts the award for CEO of the Year at the 2019 GeekWire Awards. GeekWire Photo / Kevin Lisota).

Jeff Bezos joins $76M round for secretive biotech startup led by Isilon co-founder, Stanford scientist

GeekWire

Nautilus Biotechnology co-founders Sujal Patel (left) and Parag Mallick. Mallick and Patel teamed up to create Nautilus Biotechnology. Nautilus Photo). Parag Mallick spent more than 20 years studying the intersection of software engineering and life sciences to better understand predictive and personalized medicine. Then, one weekend, a light bulb went off. The Stanford professor and cancer researcher had a big idea. He needed to start a company.

Fred Hutch’s president says a new strain of virus research center is needed to fight future outbreaks

GeekWire

“ When asked about the Seattle area’s response to the COVID-19 crisis, Lynch said he was impressed to see how tech companies including Amazon and Microsoft have been working together with biotech companies — including Adaptive Biotechnologies , which was spun out from Fred Hutch more than a decade ago. Thomas Lynch, the president and director of the Fred Hutchinson Cancer Research Center, discusses the impact of the coronavirus outbreak during a GeekWire forum.

GeekWire Awards 2020 revealed: Big winners, celebrities and surprises power virtual event

GeekWire

Other finalists are: Adaptive Biotechnologies prices IPO at $20 per share; Assurance acquired by Prudential for $2.35 Other finalists: Athira Pharma, Blaze Bioscience, Sana Biotechnology, Sound Life Sciences. Winners of the 2020 GeekWire Awards make their acceptance speeches on the live-streamed event. We couldn’t get together in person, but we still found a way to celebrate the best in Pacific Northwest tech on Thursday as the GeekWire Awards went virtual.

What is 5G Technology: 5G Connectivity and Speed Explained

Galido

In 20 years we may be familiar with holograms that transport you (like the Microsoft Hololens glasses), autonomous cars that drive alone (a concept that we see closer and closer), control devices with the mind and eyes, video games powered by the virtual reality, biotechnology that can modify your body, intelligent computers with autonomous capacity and neuromorphic chips, quantum computing, communication without barriers in different languages or the standardization of 3D (or 4D) printers.

5G Technology: Maximum Connectivity and Speed

Galido

In 20 years we may be familiar with holograms that transport you (like the Microsoft Hololens glasses), autonomous cars that drive alone (a concept that we see closer and closer), control devices with the mind and eyes, video games powered by the virtual reality, biotechnology that can modify your body, intelligent computers with autonomous capacity and neuromorphic chips, quantum computing, communication without barriers in different languages or the standardization of 3D (or 4D) printers.

Women in tech: Meet the trailblazers of STEM equality

Cloud Musings

She is a scientist and a patent attorney with a focus on biotechnology. By Sandra K. Johnson CEO, SKJ Visioneering, LLC Science, technology, engineering and mathematics (STEM) professionals are drivers of innovation,creativity and invention. STEM disciplines are significant drivers of economies worldwide, and STEM careers are rewarding and fulfilling.

Amid widespread tech industry layoffs, some companies are still hiring in a ‘flipped’ labor market

GeekWire

Other publicly-traded companies with in the Seattle region with available jobs include Impinj, Adaptive Biotechnologies , and F5 Networks , which pledged last week not to make layoffs in its current fiscal year ending in September. Hartley Riedner, new head of operations at Seattle-area startup Docugami, with CEO Jean Paoli on a video call this week. Riedner interviewed for the role and has been working at the company without yet meeting Paoli or other members of the team in person.

Week in Review: Most popular stories on GeekWire for the week of Aug. 30, 2020

GeekWire

The 35-year-old co-founder and CEO of Seattle biotechnology company Athira Pharma would be the first woman to guide a company to an initial public offering in Washington state in more than two decades. Get caught up on the latest technology and startup news from the past week.